However, whether AKT or β-catenin may function as transcription factors of c-Myc and EpCAM regulated by SLC1A4 is still unclear, and the potential regulation of SLC1A4 in tumor microenvironment represented by cancer immunity is not referred to in this study. The gene discussed is SLC1A4; the disease is cancer.